USSTOCK.TODAY
Weekend. Closed
Log in Sign up

AstraZeneca to cut approximately 600 jobs in the US to reduce costs

Investing.com · ·by G4L

AZN Astrazeneca plc
$184.45 +0.04%
View chart & analysis →
  1. 1AstraZeneca has eliminated approximately 600 jobs in its respiratory and immunology commercial operations in the US.
  2. 2AstraZeneca's one-time costs from its three-year restructuring program will reach up to $2 billion.
  3. 3AstraZeneca's annual pre-tax savings of $1.5 billion are expected to be reinvested primarily into new drug development.

So what's the key point?

AstraZeneca has reduced about 600 jobs in the US. The company plans to save $1.5 billion and reinvest those funds into developing new medicines.

Source Investing.com · View original ↗

Related 3-line summaries

AstraZeneca's $10 billion acquisition proposal for Rhythm Pharmaceuticals and obesity treatment market competition FinanceWire · 3d agoAstraZeneca Acquires Vaccine Startup; FDA Issues GLP-1 Treatment Warning BioPharma Dive · 3d agoEli Lilly widens market cap gap with Novo Nordisk in obesity treatment competition The Motley Fool +7 · 5d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news